| Product Code: ETC7916112 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Multiple Sclerosis Therapeutics Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Multiple Sclerosis Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Multiple Sclerosis Therapeutics Market - Industry Life Cycle |
3.4 Latvia Multiple Sclerosis Therapeutics Market - Porter's Five Forces |
3.5 Latvia Multiple Sclerosis Therapeutics Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Latvia Multiple Sclerosis Therapeutics Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
4 Latvia Multiple Sclerosis Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of multiple sclerosis in Latvia |
4.2.2 Growing awareness and diagnosis rates of multiple sclerosis |
4.2.3 Technological advancements in multiple sclerosis therapeutics |
4.2.4 Rising healthcare expenditure in Latvia |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of multiple sclerosis therapeutics |
4.3.2 High cost associated with multiple sclerosis treatments |
4.3.3 Limited access to specialized healthcare services in certain regions of Latvia |
5 Latvia Multiple Sclerosis Therapeutics Market Trends |
6 Latvia Multiple Sclerosis Therapeutics Market, By Types |
6.1 Latvia Multiple Sclerosis Therapeutics Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Latvia Multiple Sclerosis Therapeutics Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Latvia Multiple Sclerosis Therapeutics Market Revenues & Volume, By Immunomodulators, 2021- 2031F |
6.1.4 Latvia Multiple Sclerosis Therapeutics Market Revenues & Volume, By Immunosuppressant, 2021- 2031F |
6.2 Latvia Multiple Sclerosis Therapeutics Market, By Mode of Administration |
6.2.1 Overview and Analysis |
6.2.2 Latvia Multiple Sclerosis Therapeutics Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 Latvia Multiple Sclerosis Therapeutics Market Revenues & Volume, By Injectable, 2021- 2031F |
6.2.4 Latvia Multiple Sclerosis Therapeutics Market Revenues & Volume, By Intravenous, 2021- 2031F |
7 Latvia Multiple Sclerosis Therapeutics Market Import-Export Trade Statistics |
7.1 Latvia Multiple Sclerosis Therapeutics Market Export to Major Countries |
7.2 Latvia Multiple Sclerosis Therapeutics Market Imports from Major Countries |
8 Latvia Multiple Sclerosis Therapeutics Market Key Performance Indicators |
8.1 Average time to diagnosis of multiple sclerosis |
8.2 Patient adherence to treatment plans |
8.3 Number of clinical trials for multiple sclerosis therapeutics |
8.4 Percentage of multiple sclerosis patients receiving appropriate treatment |
8.5 Adoption rate of new multiple sclerosis therapies |
9 Latvia Multiple Sclerosis Therapeutics Market - Opportunity Assessment |
9.1 Latvia Multiple Sclerosis Therapeutics Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Latvia Multiple Sclerosis Therapeutics Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
10 Latvia Multiple Sclerosis Therapeutics Market - Competitive Landscape |
10.1 Latvia Multiple Sclerosis Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Latvia Multiple Sclerosis Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here